Intellectual Property India Publishes Patent Application for 'Eslicarbamazepine Acetate Nanosuspension Formulation For Treating Epilepsy And Method Of Preparing Thereof' Filed by Ms. Vaibhavi Prashant Bharatia

MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202521007243 A) filed by Ms. Vaibhavi Prashant Bharatia, Valsad, Gujarat, on Jan. 29, 2025, for 'eslicarbamazepine acetate nanosuspension formulation for treating epilepsy and method of preparing thereof.'

Inventor(s) include Ms. Vaibhavi Prashant Bharatia.

The application for the patent was published on Feb. 13, under issue no. 07/2026.

According to the abstract released by the Intellectual Property India: "Eslicarbamazepine acetate nanosuspension formulation for treating epilepsy and method of preparing thereof is described herein. The intranasal nanosuspension insitu gel formulation of eslicarbamazepine acetate comprises 50-80 mg % of eslicarbama...